Olga Rubio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Olga Rubio has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
A. Estella
Hospital de Jerez de la Frontera, Jerez de la Frontera, Spain
2 shared publications- Carles Subirà
Althaia Xarxa Assistencial Universitària de Manresa, Manresa, Spain
2 shared publications R. Ferrer
Hospital Universitario de Valle Hebrón, Barcelona, Spain
2 shared publications- Rafael Fernandez
CIBERES, Instituto de Salud Carlos III, Madrid, Spain
2 shared publications A. Castellanos
Área de Medicina Crítica, Hospital Universitario y Politécnico La Fe, Valencia, España
1 shared publicationAlfredo Marcos
Hospital Virgen de la Concha, Zamora, Spain
1 shared publication
Latest Publications
- 12 April 2023
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 47 (8) , 468-470
Provision of aid (POA) at the intensive care unit setting. How does it affect health professionals?
- 12 April 2023
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 47 (8) , 468-470
Provision of aid (POA) at the intensive care unit setting. How does it affect health professionals?
- 1 August 2021
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 45 (6) , 382
Reply to “Considerations on ICU triage ethics during the COVID-19 pandemic”
- 1 August 2021
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 45 (6) , 382
Reply to “Considerations on ICU triage ethics during the COVID-19 pandemic”
- 1 October 2020
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 44 (7) , 439-445
Recomendaciones éticas para la toma de decisiones difíciles en las unidades de cuidados intensivos ante la situación excepcional de crisis por la pandemia por COVID-19: revisión rápida y consenso de expertos
- 1 October 2020
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 44 (7) , 439-445
Recomendaciones éticas para la toma de decisiones difíciles en las unidades de cuidados intensivos ante la situación excepcional de crisis por la pandemia por COVID-19: revisión rápida y consenso de expertos
- 1 October 2019
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 43 (7) , 393-394
¿Resulta útil evaluar la fragilidad de los pacientes al ingreso en la unidad de cuidados intensivos (UCI)?
- 1 October 2019
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 43 (7) , 393-394
¿Resulta útil evaluar la fragilidad de los pacientes al ingreso en la unidad de cuidados intensivos (UCI)?
- Open Access
- 16 November 2018
- Published by Springer Nature in Journal of Intensive Care
- Vol. 6 (1) , 1-7
High red blood cell distribution width as a marker of hospital mortality after ICU discharge: a cohort study
High red blood cell distribution width (RDW) is associated with worse outcome in diverse scenarios, including in critical illness. The Sabadell score (SS) predicts in-hospital survival after ICU discharge. We aimed to determine RDW’s association with survival after ICU discharge and whether RDW can improve the accuracy of the SS. Retrospective cohort study. Setting: general ICU at a university hospital. We included all patients discharged to wards from January 2010 to October 2016. We analyzed associations between RDW and variables recorded on admission (age, comorbidities, severity score), during the ICU stay (treatments, complications, length of stay (LOS)), and at ICU discharge (SS). The primary outcome was hospital mortality. Statistical analysis included multivariable logistic regression and receiver operating characteristic curve (ROC) analyses. We discharged 3366 patients to wards; median ward LOS was 7 [4–13] days; ward mortality was 5.2%. Mean RDW at ICU discharge was 15.4 ± 2.5%. Ward mortality was higher at each quartile of RDW (0.7%, 2.9%, 7.5%, 10.3%; area under ROC 0.81). A logistic regression model with Sabadell score obtained an excellent accuracy for ward mortality (area under ROC 0.863), and the addition of RDW slightly improved accuracy (AUROC 0.890, p < 0.05). Recursive partitioning demonstrated higher mortality in patients with high RDW at each SS level (1.6% vs. 0.3% in SS0, 9.7% vs. 1.1% in SS1, 21.9% vs. 9.7% in SS2), but not in SS3. High RDW is a marker of severity at ICU discharge and improves the accuracy of Sabadell score in predicting ward mortality except in the more extreme SS3.
- 16 November 2018
- Published by Springer Nature in Journal of Intensive Care
- Vol. 6 (1) , 1-7
Open AccessHigh red blood cell distribution width as a marker of hospital mortality after ICU discharge: a cohort study
High red blood cell distribution width (RDW) is associated with worse outcome in diverse scenarios, including in critical illness. The Sabadell score (SS) predicts in-hospital survival after ICU discharge. We aimed to determine RDW’s association with survival after ICU discharge and whether RDW can improve the accuracy of the SS. Retrospective cohort study. Setting: general ICU at a university hospital. We included all patients discharged to wards from January 2010 to October 2016. We analyzed associations between RDW and variables recorded on admission (age, comorbidities, severity score), during the ICU stay (treatments, complications, length of stay (LOS)), and at ICU discharge (SS). The primary outcome was hospital mortality. Statistical analysis included multivariable logistic regression and receiver operating characteristic curve (ROC) analyses. We discharged 3366 patients to wards; median ward LOS was 7 [4–13] days; ward mortality was 5.2%. Mean RDW at ICU discharge was 15.4 ± 2.5%. Ward mortality was higher at each quartile of RDW (0.7%, 2.9%, 7.5%, 10.3%; area under ROC 0.81). A logistic regression model with Sabadell score obtained an excellent accuracy for ward mortality (area under ROC 0.863), and the addition of RDW slightly improved accuracy (AUROC 0.890, p < 0.05). Recursive partitioning demonstrated higher mortality in patients with high RDW at each SS level (1.6% vs. 0.3% in SS0, 9.7% vs. 1.1% in SS1, 21.9% vs. 9.7% in SS2), but not in SS3. High RDW is a marker of severity at ICU discharge and improves the accuracy of Sabadell score in predicting ward mortality except in the more extreme SS3.
- Open Access
- 13 April 2018
- Published by Springer Nature in Journal of Intensive Care
- Vol. 6 (1) , 24
Limitation of life support techniques at admission to the intensive care unit: a multicenter prospective cohort study
To determine the frequency of limitations on life support techniques (LLSTs) on admission to intensive care units (ICU), factors associated, and 30-day survival in patients with LLST on ICU admission. This prospective observational study included all patients admitted to 39 ICUs in a 45-day period in 2011. We recorded hospitals’ characteristics (availability of intermediate care units, usual availability of ICU beds, and financial model) and patients’ characteristics (demographics, reason for admission, functional status, risk of death, and LLST on ICU admission (withholding/withdrawing; specific techniques affected)). The primary outcome was 30-day survival for patients with LLST on ICU admission. Statistical analysis included multilevel logistic regression models. We recruited 3042 patients (age 62.5 ± 16.1 years). Most ICUs (94.8%) admitted patients with LLST, but only 238 (7.8% [95% CI 7.0–8.8]) patients had LLST on ICU admission; this group had higher ICU mortality (44.5 vs. 9.4% in patients without LLST; p < 0.001). Multilevel logistic regression showed a contextual effect of the hospital in LLST on ICU admission (median OR = 2.30 [95% CI 1.59–2.96]) and identified the following patient-related variables as independent factors associated with LLST on ICU admission: age, reason for admission, risk of death, and functional status. In patients with LLST on ICU admission, 30-day survival was 38% (95% CI 31.7–44.5). Factors associated with survival were age, reason for admission, risk of death, and number of reasons for LLST on ICU admission. The frequency of ICU admission with LLST is low but probably increasing; nearly one third of these patients survive for ≥ 30 days.
- 13 April 2018
- Published by Springer Nature in Journal of Intensive Care
- Vol. 6 (1) , 24
Open AccessLimitation of life support techniques at admission to the intensive care unit: a multicenter prospective cohort study
To determine the frequency of limitations on life support techniques (LLSTs) on admission to intensive care units (ICU), factors associated, and 30-day survival in patients with LLST on ICU admission. This prospective observational study included all patients admitted to 39 ICUs in a 45-day period in 2011. We recorded hospitals’ characteristics (availability of intermediate care units, usual availability of ICU beds, and financial model) and patients’ characteristics (demographics, reason for admission, functional status, risk of death, and LLST on ICU admission (withholding/withdrawing; specific techniques affected)). The primary outcome was 30-day survival for patients with LLST on ICU admission. Statistical analysis included multilevel logistic regression models. We recruited 3042 patients (age 62.5 ± 16.1 years). Most ICUs (94.8%) admitted patients with LLST, but only 238 (7.8% [95% CI 7.0–8.8]) patients had LLST on ICU admission; this group had higher ICU mortality (44.5 vs. 9.4% in patients without LLST; p < 0.001). Multilevel logistic regression showed a contextual effect of the hospital in LLST on ICU admission (median OR = 2.30 [95% CI 1.59–2.96]) and identified the following patient-related variables as independent factors associated with LLST on ICU admission: age, reason for admission, risk of death, and functional status. In patients with LLST on ICU admission, 30-day survival was 38% (95% CI 31.7–44.5). Factors associated with survival were age, reason for admission, risk of death, and number of reasons for LLST on ICU admission. The frequency of ICU admission with LLST is low but probably increasing; nearly one third of these patients survive for ≥ 30 days.